These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18679819)

  • 1. Intracranial administration of vaccinia virus complement control protein in Mo/Hu APPswe PS1dE9 transgenic mice at an early age shows enhanced performance at a later age using a cheese board maze test.
    Kulkarni AP; Pillay NS; Kellaway LA; Kotwal GJ
    Biogerontology; 2008 Dec; 9(6):405-20. PubMed ID: 18679819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of memory deficits and memory improvement with vaccinia virus complement control protein in an Alzheimer's disease model.
    Pillay NS; Kellaway LA; Kotwal GJ
    Behav Brain Res; 2008 Oct; 192(2):173-7. PubMed ID: 18490064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    O'Leary TP; Brown RE
    Behav Brain Res; 2009 Jul; 201(1):120-7. PubMed ID: 19428625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
    Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early discrimination reversal learning impairment and preserved spatial learning in a longitudinal study of Tg2576 APPsw mice.
    Zhuo JM; Prescott SL; Murray ME; Zhang HY; Baxter MG; Nicolle MM
    Neurobiol Aging; 2007 Aug; 28(8):1248-57. PubMed ID: 16828204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
    Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI
    Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of progesterone administration and APPswe+PSEN1Deltae9 mutation for cognitive performance of mid-aged mice.
    Frye CA; Walf AA
    Neurobiol Learn Mem; 2008 Jan; 89(1):17-26. PubMed ID: 17988898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related changes in visual acuity, learning and memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Stover KR; Brown RE
    Behav Brain Res; 2012 May; 231(1):75-85. PubMed ID: 22409975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Learning-memory deficit with aging in APP transgenic mice of Alzheimer's disease and intervention by using tetrahydroxystilbene glucoside.
    Zhang L; Xing Y; Ye CF; Ai HX; Wei HF; Li L
    Behav Brain Res; 2006 Oct; 173(2):246-54. PubMed ID: 16901557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease.
    Reiserer RS; Harrison FE; Syverud DC; McDonald MP
    Genes Brain Behav; 2007 Feb; 6(1):54-65. PubMed ID: 17233641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A detailed analysis of the early context extinction deficits seen in APPswe/PS1dE9 female mice and their relevance to preclinical Alzheimer's disease.
    Bonardi C; de Pulford F; Jennings D; Pardon MC
    Behav Brain Res; 2011 Sep; 222(1):89-97. PubMed ID: 21440575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice.
    Hyde LA; Kazdoba TM; Grilli M; Lozza G; Brusa R; Zhang Q; Wong GT; McCool MF; Zhang L; Parker EM; Higgins GA
    Behav Brain Res; 2005 May; 160(2):344-55. PubMed ID: 15863231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-dependent phenotypic characteristics of a triple transgenic mouse model of Alzheimer disease.
    Pietropaolo S; Feldon J; Yee BK
    Behav Neurosci; 2008 Aug; 122(4):733-47. PubMed ID: 18729626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease.
    Filali M; Lalonde R
    Brain Res; 2009 Oct; 1292():93-9. PubMed ID: 19643098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial learning and memory impairment and increased locomotion in a transgenic amyloid precursor protein mouse model of Alzheimer's disease.
    Walker JM; Fowler SW; Miller DK; Sun AY; Weisman GA; Wood WG; Sun GY; Simonyi A; Schachtman TR
    Behav Brain Res; 2011 Sep; 222(1):169-75. PubMed ID: 21443906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
    Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW
    J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prodynorphin knockout mice demonstrate diminished age-associated impairment in spatial water maze performance.
    Nguyen XV; Masse J; Kumar A; Vijitruth R; Kulik C; Liu M; Choi DY; Foster TC; Usynin I; Bakalkin G; Bing G
    Behav Brain Res; 2005 Jun; 161(2):254-62. PubMed ID: 15922052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive and non-cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer's disease.
    Filali M; Lalonde R; Rivest S
    Genes Brain Behav; 2009 Mar; 8(2):143-8. PubMed ID: 19077180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygen treatment triggers cognitive impairment in Alzheimer's transgenic mice.
    Arendash GW; Cox AA; Mori T; Cracchiolo JR; Hensley KL; Roberts LJ
    Neuroreport; 2009 Aug; 20(12):1087-92. PubMed ID: 19543132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral aluminum exposure on behavior and neurogenesis in a transgenic mouse model of Alzheimer's disease.
    Ribes D; Colomina MT; Vicens P; Domingo JL
    Exp Neurol; 2008 Dec; 214(2):293-300. PubMed ID: 18834880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.